ZSWIM1 inhibitors are a class of chemical compounds designed to specifically target the ZSWIM1 protein, which belongs to the zinc finger SWIM-type domain-containing family. ZSWIM1 is known to be involved in protein-protein interactions, often acting as a scaffold or regulator within cellular pathways. The SWIM domain, a conserved motif found in proteins that are implicated in ubiquitin-related processes, allows ZSWIM1 to interact with other proteins involved in the ubiquitination machinery, which is critical for the degradation of proteins via the proteasome. Inhibitors of ZSWIM1 disrupt its function, potentially altering ubiquitin signaling or interfering with its interactions with key regulatory proteins. This disruption may have downstream effects on protein stability and degradation, impacting various cellular processes dependent on protein turnover.
By inhibiting ZSWIM1, these compounds could affect the regulation of proteins targeted for ubiquitination, particularly those involved in cell cycle regulation, DNA repair, or stress responses. ZSWIM1 is believed to participate in pathways that ensure the proper tagging of proteins with ubiquitin, marking them for degradation or altering their activity within the cell. Blocking ZSWIM1 function with specific inhibitors may impair these processes, leading to the accumulation of proteins that are normally degraded or a failure to regulate proteins that require modification. This interference provides researchers with a valuable tool to investigate the precise role of ZSWIM1 in ubiquitination pathways and its broader impact on cellular homeostasis. Through the use of ZSWIM1 inhibitors, it is possible to explore the molecular mechanisms underlying protein regulation and the intricate balance maintained by ubiquitin signaling in cells.
SEE ALSO...
Items 11 to 20 of 24 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate, a histone deacetylase inhibitor, may promote ZSWIM1 expression by enhancing histone acetylation and transcriptional activation. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Lysosomotropic agent, can affect autophagy, potentially influencing pathways involving ZSWIM1. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin Gallate inhibits DNA methyltransferases, which could result in hypomethylation and potential upregulation of ZSWIM1 expression. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $65.00 $261.00 | 113 | |
Inhibits autophagy by blocking autophagosome formation, potentially impacting ZSWIM1-related pathways. | ||||||
hydroxychloroquine | 118-42-3 | sc-507426 | 5 g | $57.00 | 1 | |
Autophagy inhibitor, may indirectly affect processes related to ZSWIM1. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates SIRT1, which may lead to changes in chromatin structure and impact the transcriptional regulation of ZSWIM1. | ||||||
SMER28 | 307538-42-7 | sc-222320 | 10 mg | $173.00 | ||
Autophagy enhancer, could have indirect effects on pathways involving ZSWIM1. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc acts as a cofactor for DNA-binding proteins and may influence ZSWIM1 gene expression through modulation of transcription factor activity. | ||||||
Copper(II) sulfate | 7758-98-7 | sc-211133 sc-211133A sc-211133B | 100 g 500 g 1 kg | $46.00 $122.00 $189.00 | 3 | |
Copper can act as a cofactor for various enzymes, potentially affecting the transcriptional regulation of genes like ZSWIM1. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor, potentially affecting protein synthesis and degradation pathways involving ZSWIM1. | ||||||